HOLDRS Merrill Lynch Pharmaceutical (pph)
Last Updated by WikiWealth | Update This Page Now
Asset Allocation (% of Port)
Geographic Allocation (% of Port)
Australia + Pacific Islands
ETF Description Update
HOLDRS Merrill Lynch Pharmaceutical (PPH) Description: PPH is an exchange trading fund (ETF), which is a security that tracks a basket of assets, but trades like a stock. PPH exchange trading fund (ETF) tracks the General Pharaceutical Index; this etf is not linked to a specific benchmark. HOLDRS Merrill Lynch Pharmaceutical (PPH) falls under the Health & Biotech Equities category. PPH's dividend yield is roughly 2.55%, it has an expense ratio of 0.5%, and is in the equity ETF asset class. HOLDRS Merrill Lynch Pharmaceutical (PPH) focuses its investments in the U.S. region of the world. PPH does not use leverage and PPH's performance is meant to match its benchmark. The PPH ETF belongs to the Health & Biotech sector. An investor can find PPH's top holdings, fundamental analysis, and fund ratings on the left side of the screen. The right side features PPH's technical analysis chart and long term fund potential. Long term and short term buy ratings indicate our highest possible valuation rating. Click here for additional information on Merrill Lynch HOLDRs ETF funds or see the ETF research & analysis home page to start.
Be the first to explain HOLDRS Merrill Lynch Pharmaceutical (PPH)'s strategy.